article · Zenodo (CERN European Organization for Nuclear Research)
Abstract Background: Oral mucositis (OM) is a common debilitating side effect induced by methotrexate (MTX). Quercetin (QRC) is a natural flavonoid with anti-inflammatory and antioxidant properties. Formulating QRC in nanoemulsion (QRC-NE) may enhance its biological effects and therapeutic potential. Aim: This study evaluated the histopathological and immunohistochemical effects of QRC-NE on MTX-induced lingual mucositis in albino rats. Material and Methods: Fifty animals were randomly divided into five groups: Negative control (healthy), MTX-treated (a single i.p. 20 mg/kg on day 11), QRC-treated (50 mg/kg orally, 16 days), QRC+MTX and QRC-NE+MTX (QRC 50 mg/kg and QRC-NE 12.5 mg/kg, respectively, orally as a prophylactic to OM, 16 days + MTX a single i.p. 20 mg/kg on day 11). Rats were euthanized on day 17. The anterior two-thirds of tongue specimens were processed for histological assessment by H&E and Masson Trichrome staining, and Caspase-3 IHC expression. Data were analyzed using the one-way ANOVA and Bonferroni post-hoc tests. Results: MTX group revealed marked histological destruction in the lingual mucosa with reduced collagen density and strong caspase-3 expression compared to the negative control (p≤0.05). QRC-NE treatment showed significantly preserved mucosal architecture, increased collagen density, and exhibited mild caspase-3 expression compared to MTX (p≤0.05). Conclusions: QRC-NE has a modulatory effect on MTX-induced lingual mucositis, suggesting a potential role for nano-based QRC administration in alleviating oral mucosal injury.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5281/zenodo.18617972
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.